M. Manning

3.8k total citations
71 papers, 3.1k citations indexed

About

M. Manning is a scholar working on Social Psychology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Manning has authored 71 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Social Psychology, 28 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Manning's work include Neuroendocrine regulation and behavior (55 papers), Receptor Mechanisms and Signaling (17 papers) and Electrolyte and hormonal disorders (16 papers). M. Manning is often cited by papers focused on Neuroendocrine regulation and behavior (55 papers), Receptor Mechanisms and Signaling (17 papers) and Electrolyte and hormonal disorders (16 papers). M. Manning collaborates with scholars based in United States, France and Italy. M. Manning's co-authors include W. H. Sawyer, Bice Chini, Gilles Guillon, S. Stoev, Bernard Mouillac, Thierry Durroux, Wood Yee Chan, Serge Jard, K. Bańkowski and Aleksandra Olma and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Manning

70 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Manning United States 28 2.4k 1.0k 952 671 613 71 3.1k
Maurice Manning United States 33 2.5k 1.0× 1.0k 1.0× 1.3k 1.4× 728 1.1× 901 1.5× 72 3.5k
Gilles Guillon France 39 2.5k 1.0× 1.1k 1.1× 2.3k 2.5× 970 1.4× 1.0k 1.7× 166 5.7k
W. H. Sawyer United States 27 1.6k 0.7× 614 0.6× 676 0.7× 638 1.0× 495 0.8× 74 2.4k
Jack Elands Netherlands 18 1.4k 0.6× 662 0.7× 640 0.7× 133 0.2× 650 1.1× 30 1.9k
Jaya Haldar United States 21 1.3k 0.5× 528 0.5× 366 0.4× 319 0.5× 378 0.6× 44 1.6k
William G. North United States 27 958 0.4× 394 0.4× 618 0.6× 589 0.9× 425 0.7× 102 2.0k
Regis R. Vollmer United States 27 913 0.4× 629 0.6× 543 0.6× 50 0.1× 270 0.4× 56 2.1k
Aleksandra Olma Poland 17 798 0.3× 295 0.3× 475 0.5× 207 0.3× 259 0.4× 51 1.1k
Teruyuki Yanagisawa Japan 29 575 0.2× 223 0.2× 1.5k 1.6× 91 0.1× 597 1.0× 130 3.1k
Annegret Blume Germany 23 609 0.3× 208 0.2× 788 0.8× 57 0.1× 594 1.0× 37 2.3k

Countries citing papers authored by M. Manning

Since Specialization
Citations

This map shows the geographic impact of M. Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Manning more than expected).

Fields of papers citing papers by M. Manning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Manning. The network helps show where M. Manning may publish in the future.

Co-authorship network of co-authors of M. Manning

This figure shows the co-authorship network connecting the top 25 collaborators of M. Manning. A scholar is included among the top collaborators of M. Manning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Manning. M. Manning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manning, M., Aleksandra Misicka, Aleksandra Olma, et al.. (2012). Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. Journal of Neuroendocrinology. 24(4). 609–628. 330 indexed citations
2.
Mouillac, Bernard, M. Manning, & Thierry Durroux. (2008). Fluorescent Agonists and Antagonists for Vasopressin/Oxytocin G Protein-Coupled Receptors: Usefulness in Ligand Screening Assays and Receptor Studies. Mini-Reviews in Medicinal Chemistry. 8(10). 996–1005. 21 indexed citations
3.
Manning, M., S. Stoev, Bice Chini, et al.. (2008). Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆. Progress in brain research. 170. 473–512. 230 indexed citations
4.
Chini, Bice, M. Manning, & Gilles Guillon. (2008). Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology. Progress in brain research. 170. 513–517. 47 indexed citations
5.
Manning, M., S. Stoev, Ling Cheng, Nga Ching Wo, & Wood Yee Chan. (1999). Discovery and Design of Novel Vasopresses Hypotensive Pepitide Agonists. Journal of Receptors and Signal Transduction. 19(1-4). 631–644. 8 indexed citations
6.
Hibert, Marcel, Jan Hoflack, Susanne Trumpp-Kallmeyer, et al.. (1999). Functional Architecture of Vasopressin/Oxytocin Receptors. Journal of Receptors and Signal Transduction. 19(1-4). 589–596. 28 indexed citations
7.
Chan, Wood Yee, Nga Ching Wo, S. Stoev, Ling Cheng, & M. Manning. (1998). Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors. British Journal of Pharmacology. 125(4). 803–811. 15 indexed citations
8.
Arsenijévic, Yvan, Michel Dubois‐Dauphin, E. Tribollet, et al.. (1994). Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe. Journal of Endocrinology. 141(3). 383–391. 21 indexed citations
9.
Chan, Wood Yee, et al.. (1993). Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations.. Endocrinology. 132(3). 1381–1386. 44 indexed citations
10.
Manning, M., S. Stoev, Wood Yee Chan, & W. H. Sawyer. (1993). Receptor‐Specific Antagonists of Vasopressin and Oxytocin. Annals of the New York Academy of Sciences. 689(1). 219–232. 17 indexed citations
11.
Sawyer, W. H., et al.. (1991). Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position. Cellular and Molecular Life Sciences. 47(1). 83–86. 1 indexed citations
12.
Schmidt, Anne, S. Audigier, Claude Barberis, et al.. (1991). A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V1a receptors. FEBS Letters. 282(1). 77–81. 75 indexed citations
13.
Kruszynski, Marian, M. Manning, Nga Ching Wo, & W. H. Sawyer. (1990). Invertebrate neuropeptides resembling vasotocin and some analogues: Synthesis and pharmacological properties. Cellular and Molecular Life Sciences. 46(7). 771–773. 7 indexed citations
14.
Sawyer, W. H., K. Bańkowski, Aleksandra Misicka, et al.. (1988). Potent V2 vasopressin antagonists with structural changes at their C-terminals. Peptides. 9(1). 157–163. 23 indexed citations
15.
Manning, M., Jacek Przybylski, Aleksandra Olma, et al.. (1987). No requirement of cyclic conformation of antagonists in binding to vasopressin receptors. Nature. 329(6142). 839–840. 62 indexed citations
16.
Manning, M., Aleksandra Misicka, Aleksandra Olma, et al.. (1987). C-Terminal deletions in antagonistic analogs of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. Journal of Medicinal Chemistry. 30(12). 2245–2252. 25 indexed citations
17.
Jard, Serge, Rolf C. Gaillard, Gilles Guillon, et al.. (1986). Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.. Molecular Pharmacology. 30(2). 171–177. 227 indexed citations
18.
19.
Sawyer, W. H., et al.. (1969). 4-Proline Analogues of Neurohypophysial Hormones: Hypothetical Intermediates in Peptide Evolution. Endocrinology. 85(2). 385–388. 12 indexed citations
20.
Manning, M., et al.. (1969). Solid phase synthesis and some pharmacological properties of 8-glutamine-oxytocin: a possible intermediate in the evolution of the neurohypophysial hormones. Cellular and Molecular Life Sciences. 25(11). 1127–1128. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurice Manning Breakdown of academic impact, for papers by Gilles Guillon Breakdown of academic impact, for papers by W. H. Sawyer Breakdown of academic impact, for papers by Jack Elands Breakdown of academic impact, for papers by Jaya Haldar Breakdown of academic impact, for papers by William G. North Breakdown of academic impact, for papers by Regis R. Vollmer Breakdown of academic impact, for papers by Aleksandra Olma Breakdown of academic impact, for papers by Teruyuki Yanagisawa Breakdown of academic impact, for papers by Annegret Blume
Rankless by CCL
2026